Nationwide cross-sectional study results on long-term care and SARS-CoV-2 infection among older a...

Nationwide cross-sectional study results on long-term care and SARS-CoV-2 infection among older adults in Germany during the COVID-19 pandemic  Nature

First vaccine against SARS virus family enters human trials - UW Medicine - Newsroom

First vaccine against SARS virus family enters human trials  UW Medicine - Newsroom

Metformin’s Prospective Role in Preventing Long COVID - Contagion Live

Metformin’s Prospective Role in Preventing Long COVID  Contagion Live

A Tiny Antibody Just Crushed the Coronavirus’s Secret Weak Spot - SciTechDaily

A Tiny Antibody Just Crushed the Coronavirus’s Secret Weak Spot  SciTechDaily

Coronavirus disease (COVID-19) - World Health Organization (WHO)

Coronavirus disease (COVID-19)  World Health Organization (WHO)

Surveillance and Data Analytics | COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

Surveillance and Data Analytics | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

A common diabetes drug may prevent long COVID when taken early - News-Medical

A common diabetes drug may prevent long COVID when taken early  News-Medical

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study  The Lancet

Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 ind...

Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2  Nature

Fall Respiratory Virus Update: COVID-19, Flu, RSV - Rush University System for Health

Fall Respiratory Virus Update: COVID-19, Flu, RSV  Rush University System for Health

UCLA study reveals dual forces driving SARS-CoV-2 Evolution: Immune pressure and viral fitness - ...

UCLA study reveals dual forces driving SARS-CoV-2 Evolution: Immune pressure and viral fitness  EurekAlert!

COVID-19 viral fragments shown to target and kill specific immune cells in UCLA-led study - UCLA

COVID-19 viral fragments shown to target and kill specific immune cells in UCLA-led study  UCLA

COVID-19: how worried should we be about the Frankenstein variant? | - pasteur.fr

COVID-19: how worried should we be about the Frankenstein variant? |  pasteur.fr

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID  Johns Hopkins Medicine

COVID-19 | Yellow Book - Centers for Disease Control and Prevention | CDC (.gov)

COVID-19 | Yellow Book  Centers for Disease Control and Prevention | CDC (.gov)

WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)

WHO Scientific advisory group issues report on origins of COVID-19  World Health Organization (WHO)

SARS-CoV-2 origins: imperfect but clear evidence - The Lancet

SARS-CoV-2 origins: imperfect but clear evidence  The Lancet

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspri...

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspring in a sex-dependent manner  Nature

A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure ...

A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19  Nature

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its ba...

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base  Nature

SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine

SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina  Yale School of Medicine

Long COVID after SARS-CoV-2 during pregnancy in the United States - Nature

Long COVID after SARS-CoV-2 during pregnancy in the United States  Nature

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)

Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

Types of COVID-19 Treatment - Centers for Disease Control and Prevention | CDC (.gov)

Types of COVID-19 Treatment  Centers for Disease Control and Prevention | CDC (.gov)

In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 variants of inte...

In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 variants of interest  Nature

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies - Nature

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies  Nature

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein - Nature

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein  Nature

Wastewater surveillance reveals hidden COVID spread beyond reported cases - News-Medical

Wastewater surveillance reveals hidden COVID spread beyond reported cases  News-Medical

Metformin Shows Promise as a Preventive Treatment for Long COVID - Technology Networks

Metformin Shows Promise as a Preventive Treatment for Long COVID  Technology Networks

Testing for COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

Testing for COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)

Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

Is COVID Still Here? - Cleveland Clinic

Is COVID Still Here?  Cleveland Clinic

A calibration of nucleic acid (PCR) by antibody (IgG) tests in Germany: the course of SARS-CoV-2 ...

A calibration of nucleic acid (PCR) by antibody (IgG) tests in Germany: the course of SARS-CoV-2 infections estimated  Frontiers

COVID is still evolving and will find new ways to evade immune systems, scientists say - NPR

COVID is still evolving and will find new ways to evade immune systems, scientists say  NPR

How to Protect Yourself and Others | COVID-19 - Centers for Disease Control and Prevention | CDC ...

How to Protect Yourself and Others | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Lab Leak: The True Origins of Covid-19 - The White House (.gov)

Lab Leak: The True Origins of Covid-19  The White House (.gov)

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Tar...

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family  PR Newswire

COVID-19 (SARS-CoV-2 virus) - pasteur.fr

COVID-19 (SARS-CoV-2 virus)  pasteur.fr

Coronavirus Disease 2019 (COVID-19) - Centers for Disease Control and Prevention | CDC (.gov)

Coronavirus Disease 2019 (COVID-19)  Centers for Disease Control and Prevention | CDC (.gov)

SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (NIH) | (...

SARS-CoV-2 fragments may cause problems after infection  National Institutes of Health (NIH) | (.gov)

Targeting the SARS-CoV-2 reservoir in long COVID - The Lancet

Targeting the SARS-CoV-2 reservoir in long COVID  The Lancet

Characteristics of SARS-CoV-2 and COVID-19 - Nature

Characteristics of SARS-CoV-2 and COVID-19  Nature

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review a...

SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis  Nature

About COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)

About COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Coronavirus disease (COVID-19) - World Health Organization (WHO)

Coronavirus disease (COVID-19)  World Health Organization (WHO)

How SARS-CoV-2 Evolved Through the COVID Pandemic - WCM Newsroom

How SARS-CoV-2 Evolved Through the COVID Pandemic  WCM Newsroom

SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature

SARS-CoV-2 infection and persistence in the human body and brain at autopsy  Nature

Mechanisms of SARS-CoV-2 entry into cells - Nature

Mechanisms of SARS-CoV-2 entry into cells  Nature

Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children - The New England...

Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children  The New England Journal of Medicine

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus - Frontiers

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus  Frontiers

SARS-CoV-2 Variants in Patients with Immunosuppression - The New England Journal of Medicine

SARS-CoV-2 Variants in Patients with Immunosuppression  The New England Journal of Medicine

Widespread exposure to SARS-CoV-2 in wildlife communities - Nature

Widespread exposure to SARS-CoV-2 in wildlife communities  Nature

Tracking SARS-CoV-2 variants - World Health Organization (WHO)

Tracking SARS-CoV-2 variants  World Health Organization (WHO)

Severe Acute Respiratory Syndrome (SARS) - World Health Organization (WHO)

Severe Acute Respiratory Syndrome (SARS)  World Health Organization (WHO)

SARS-CoV-2 in Animals - aphis.usda.gov

SARS-CoV-2 in Animals  aphis.usda.gov

SARS-CoV-2 pathogenesis - Nature

SARS-CoV-2 pathogenesis  Nature

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets - Nature

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets  Nature

Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...

Transmission of SARS-CoV-2: implications for infection prevention precautions  World Health Organization (WHO)

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels  Nature

SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus) - PNAS

SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus)  PNAS

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...

SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows  Centers for Disease Control and Prevention | CDC (.gov)

COVID-19 Resources (SARS-CoV-2 Coronavirus) - American Society for Microbiology

COVID-19 Resources (SARS-CoV-2 Coronavirus)  American Society for Microbiology

The proximal origin of SARS-CoV-2 - Nature

The proximal origin of SARS-CoV-2  Nature

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronav...

Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection  Nature

Outbreak of SARS-CoV-2 Infections, including COVID-19 ... - Centers for Disease Control and Preve...

Outbreak of SARS-CoV-2 Infections, including COVID-19 ...  Centers for Disease Control and Prevention | CDC (.gov)

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics  Nature

How does SARS-CoV-2 cause COVID-19? - Science | AAAS

How does SARS-CoV-2 cause COVID-19?  Science | AAAS

The evolution of SARS-CoV-2 - Nature

The evolution of SARS-CoV-2  Nature

Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States - Nature

Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States  Nature

Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 | MMWR - Centers...

Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 | MMWR  Centers for Disease Control and Prevention | CDC (.gov)

Prevalence of persistent SARS-CoV-2 in a large community surveillance study - Nature

Prevalence of persistent SARS-CoV-2 in a large community surveillance study  Nature

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 - Nature

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19  Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic - Nature

Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic  Nature

The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...

The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2  Nature

SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19...

SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19  Nature

SARS-CoV-2 viral load and shedding kinetics - Nature

SARS-CoV-2 viral load and shedding kinetics  Nature

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 - The New England Journa...

Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19  The New England Journal of Medicine

Long COVID after breakthrough SARS-CoV-2 infection - Nature

Long COVID after breakthrough SARS-CoV-2 infection  Nature

Innate immune evasion strategies of SARS-CoV-2 - Nature

Innate immune evasion strategies of SARS-CoV-2  Nature

Structures and functions of coronavirus replication–transcription complexes and their relevance f...

Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design  Nature

Coronavirus biology and replication: implications for SARS-CoV-2 - Nature

Coronavirus biology and replication: implications for SARS-CoV-2  Nature

The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-se...

The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China  The Lancet

New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic - Frontiers

New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic  Frontiers

Coronaviruses Have Been Around For Centuries: What Differentiates COVID-19? - Cleveland Clinic

Coronaviruses Have Been Around For Centuries: What Differentiates COVID-19?  Cleveland Clinic

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection - The New England...

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection  The New England Journal of Medicine

A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of...

A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection  Nature

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic - The Lancet

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic  The Lancet

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis ...

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis  The Lancet

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England - Science | AAAS

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England  Science | AAAS

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls - Nature

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls  Nature

The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 - Science | AAAS

The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2  Science | AAAS

SARS-CoV-2 vaccines in development - Nature

SARS-CoV-2 vaccines in development  Nature

The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory ...

The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells  Nature

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors - Nature

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors  Nature

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug develo...

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19  Nature

Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 year...

Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection  Nature

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)  Nature

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1  The New England Journal of Medicine

Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and in...

Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection | Signal Transduction and Targeted Therapy  Nature